User profiles for Dominik Vonficht
Dominik VonfichtDKFZ Verified email at dkfz-heidelberg.de Cited by 633 |
[HTML][HTML] Vitamin A-retinoic acid signaling regulates hematopoietic stem cell dormancy
Dormant hematopoietic stem cells (dHSCs) are atop the hematopoietic hierarchy. The
molecular identity of dHSCs and the mechanisms regulating their maintenance or exit from …
molecular identity of dHSCs and the mechanisms regulating their maintenance or exit from …
[HTML][HTML] Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states
Single-cell genomics technology has transformed our understanding of complex cellular
systems. However, excessive cost and a lack of strategies for the purification of newly identified …
systems. However, excessive cost and a lack of strategies for the purification of newly identified …
[HTML][HTML] Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
…, H Köse, K Isaakidis, D Vonficht… - The Journal of …, 2022 - Am Soc Clin Investig
Activated SUMOylation is a hallmark of cancer. Starting from a targeted screening for SUMO-regulated
immune evasion mechanisms, we identified an evolutionarily conserved function …
immune evasion mechanisms, we identified an evolutionarily conserved function …
[HTML][HTML] Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
…, SM Tirier, JP Mallm, S Schumacher, D Vonficht… - Nature …, 2023 - nature.com
In multiple myeloma spatial differences in the subclonal architecture, molecular signatures
and composition of the microenvironment remain poorly characterized. To address this …
and composition of the microenvironment remain poorly characterized. To address this …
[HTML][HTML] Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
…, B Neuber, A Kunz, P Waldhoff, D Vonficht… - Journal of Hematology & …, 2023 - Springer
Background Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs)
might improve clinical outcome of patients with B cell malignancies. This is the first report on …
might improve clinical outcome of patients with B cell malignancies. This is the first report on …
[PDF][PDF] Antigen presentation safeguards the integrity of the hematopoietic stem cell pool
P Hernández-Malmierca, D Vonficht, A Schnell… - Cell Stem Cell, 2022 - cell.com
Hematopoietic stem and progenitor cells (HSPCs) are responsible for the production of blood
and immune cells. Throughout life, HSPCs acquire oncogenic aberrations that can cause …
and immune cells. Throughout life, HSPCs acquire oncogenic aberrations that can cause …
[HTML][HTML] Globally altered epigenetic landscape and delayed osteogenic differentiation in H3. 3-G34W-mutant giant cell tumor of bone
…, F Rosemann, K Breuer, D Vonficht… - Nature …, 2020 - nature.com
The neoplastic stromal cells of giant cell tumor of bone (GCTB) carry a mutation in H3F3A,
leading to a mutant histone variant, H3.3-G34W, as a sole recurrent genetic alteration. We …
leading to a mutant histone variant, H3.3-G34W, as a sole recurrent genetic alteration. We …
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation
Co-inhibitory and checkpoint molecules suppress T cell function in the tumor microenvironment,
thereby rendering T cells dysfunctional. Although immune checkpoint blockade is a …
thereby rendering T cells dysfunctional. Although immune checkpoint blockade is a …
[PDF][PDF] Aged intestinal stem cells propagate cell-intrinsic sources of inflammaging in mice
Low-grade chronic inflammation is a hallmark of ageing, associated with impaired tissue
function and disease development. However, how cell-intrinsic and -extrinsic factors collectively …
function and disease development. However, how cell-intrinsic and -extrinsic factors collectively …
Bone marrow immune signatures in multiple myeloma are linked to tumor heterogeneity and treatment outcome
…, A Baumann, N Hefner, S Schumacher, D Vonficht… - Blood, 2022 - ashpublications.org
In multiple myeloma (MM), malignant plasma cells interact with a bone marrow microenvironment
(BME) that promotes disease progression and drug resistance. Anti-CD38 monoclonal …
(BME) that promotes disease progression and drug resistance. Anti-CD38 monoclonal …